BillionToOne ctDNA Assay Shows 94% Concordance in Study

BillionToOne's tissue-free Northstar Response ctDNA assay demonstrated 94% directional concordance with a tumor-informed test in a peer-reviewed head-to-head study. The assay also matched clinical ground truth in all discordant cases.